Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The role of oxidative stress in the pathogenesis of Reticular Dysgenesis and thetherapeutic potential of antioxidants
Neural Modeling and Imaging of Speech
Structural Basis for Isoprenoid Biosynthesis
Cytokinesis and Cell Polarity in C Elegans Embryos
Signal Processing for Passive RF Sensing
Recently added grants:
Development Core
Cognitive Training for Emotion Regulation in Psychotic Disorders
Methods Core
Policy Impact Core
Combination Prevention Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43308-6-0-1
Application #
7587174
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Washington University
$1,406,468
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
You, Ming /
$1,882,921
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant